The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis
- PMID: 23103172
- PMCID: PMC3530297
- DOI: 10.1016/S1473-3099(12)70238-4
The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis
Abstract
Background: Invasive community-onset staphylococcal disease has emerged worldwide associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an epidemiological marker is unclear. We investigate the role of PVL in disease, colonisation, and clinical outcome.
Methods: We searched Medline and Embase for original research reporting the prevalence of PVL genes among Staphylococcus aureus pneumonia, bacteraemia, musculoskeletal infection, skin and soft-tissue infection, or colonisation published before Oct 1, 2011. We calculated odds ratios (ORs) to compare patients with PVL-positive colonisation and each infection relative to the odds of PVL-positive skin and soft-tissue infection. We did meta-analyses to estimate odds of infection or colonisation with a PVL-positive strain with fixed-effects or random-effects models, depending on the results of tests for heterogeneity.
Results: Of 509 articles identified by our search strategy, 76 studies from 31 countries met our inclusion criteria. PVL strains are strongly associated with skin and soft-tissue infections, but are comparatively rare in pneumonia (OR 0·37, 95% CI 0·22-0·63), musculoskeletal infections (0·44, 0·19-0·99), bacteraemias (0·10, 0·06-0·18), and colonising strains (0·07, 0·01-0·31). PVL-positive skin and soft-tissue infections are more likely to be treated surgically than are PVL-negative infections, and children with PVL-positive musculoskeletal disease might have increased morbidity. For other forms of disease we identified no evidence that PVL affects outcome.
Interpretation: PVL genes are consistently associated with skin and soft-tissue infections and are comparatively rare in invasive disease. This finding challenges the view that PVL mainly causes invasive disease with poor prognosis. Population-based studies are needed to define the role of PVL in mild, moderate, and severe disease and to inform control strategies.
Funding: None.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Figures







Comment in
-
Panton-Valentine leucocidin and staphylococcal disease.Lancet Infect Dis. 2013 Jan;13(1):5-6. doi: 10.1016/S1473-3099(12)70265-7. Epub 2012 Oct 26. Lancet Infect Dis. 2013. PMID: 23103174 No abstract available.
-
Panton-Valentine leucocidin and pneumonia.Lancet Infect Dis. 2013 Jul;13(7):566. doi: 10.1016/S1473-3099(13)70102-6. Lancet Infect Dis. 2013. PMID: 23809217 No abstract available.
-
Panton-Valentine leucocidin and pneumonia--authors' reply.Lancet Infect Dis. 2013 Jul;13(7):566-567. doi: 10.1016/S1473-3099(13)70152-X. Lancet Infect Dis. 2013. PMID: 23809218 No abstract available.
References
-
- Gorwitz RJ, Kruszon-Moran D, McAllister SK. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis. 2008;197:1226–1234. - PubMed
-
- Diekema DJ, Pfaller MA, Schmitz FJ. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis. 2001;32:S114–S132. - PubMed
-
- Jevons MP, Coe AW, Parker MT. Methicillin resistance in staphylococci. Lancet. 1963;281:904–907. - PubMed
-
- Kaneko J, Kamio Y. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem. 2004;68:981–1003. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous